Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prospective Exploratory Study on rTMS for Migraine Under the Guidance of MEG
Sponsor: Ruijin Hospital
Summary
Using magnetoencephalography to locate and regulate targets in migraine patients, repeating transcranial magnetic stimulation to physically regulate targets, and evaluating the safety and effectiveness of this treatment method through headache related scales. Using whole genome data and scale scores for correlation analysis, and conducting randomized controls with traditional drugs to explore new approaches for migraine.
Key Details
Gender
All
Age Range
15 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-02-06
Completion Date
2026-06-30
Last Updated
2025-02-11
Healthy Volunteers
No
Interventions
rTMS
(1) The patient undergoes pseudo stimulus intervention in the first week and real stimulus intervention afterwards, which is blind to the patient. (2) Starting from the second week, true stimulation intervention will be conducted for 4 weeks, with each patient making an appointment for 1 month. On Day 7 after the patient intervention, Day 14, Day 30, Day 60, Day 90, Day 180 scales were used to evaluate follow-up.
Sibelium
Sibelium 10mg is taken orally every night for 4 weeks each course of treatment. Patients were evaluated and followed up with a scale based on medication intervention, including Day 7, Day 14, Day 30, Day 60, Day 90, and Day 180
Locations (1)
Ruijin Hospital
Shanghai, China